Table 1.
Mucoactive drugs | Potential mechanism of action |
---|---|
Expectorants | |
Hypertonic saline | Increases secretion volume and/or hydration |
Guaifenesin | Stimulates secretion and reduces mucus viscosity |
Mucus regulators | |
Carbocysteine | Metabolism of mucus-producing cells, antioxidant and anti-inflammatory effects, modulates mucus production |
Anticholinergic agents | Decrease secretion volume |
Glucocorticoids | Reduce airway inflammation and mucin secretion |
Macrolide antibiotics | Reduce airway inflammation and mucin secretion |
Mucolytics | |
N-acetylcysteine | Breaks disulfide bonds linking mucin polymers, antioxidant and anti-inflammatory effects |
Nacystelyn | Increases chloride secretion and disulfide bonds |
Erdosteine | Modulates mucus production and increases mucociliary transport |
Dornase alfa | Hydrolyzes the DNA in mucus and reduces viscosity in the lungs |
Gelsolin | Severs actin filament cross-links |
Thymosin β4 | Severs actin filament cross-links |
Dextran | Breaks hydrogen bonds and increases secretion hydration |
Heparin | Breaks hydrogen bonds and ionic bonds |
Mucokinetics | |
Bronchodilators | Improve cough clearance by increasing expiratory flow |
Surfactants | Decrease sputum/mucus adhesiveness |
Ambroxol | Stimulates surfactant production and inhibits neuronal sodium channels |
Note: Reproduced with permission from the © ERS 2010. European Respiratory Review Jun 2010, 19(116):127–133; DOI: 10.1183/09059180.00003510.43